Yu J, Sweeting AN, Gianacas C, Houston L, et al. The effects of canagliflozin in type 2 diabetes in subgroups defined by population-specific body mass index: Insights from the CANVAS Program and CREDENCE trial. Diabetes Obes Metab 2023 Sep 6. doi: 10.1111/dom.15267.
PMID: 37671609